ABK Biomedical Inc of HALIFAX, A5, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-22. The offering totals $23.5M, of which $23.5M was reported sold. Industry: Biotechnology.
Showing 25 of 32 people.
| Name | Role | Location |
|---|---|---|
| Bob Abraham | Related Person | Halifax, A5 |
| Aaron Berez | Related Person | Halifax, A5 |
| David Dobrowski | Related Person | Halifax, A5 |
| Gary Donofrio | Related Person | Halifax, A5 |
| Marc Gregoire | Related Person | Halifax, A5 |
| Michael Mangano | Related Person | Halifax, A5 |
| James McLaren | Related Person | Halifax, A5 |
| ROBERT ORR | Related Person | Halifax, A5 |
| Michael Tyson | Related Person | Halifax, A5 |
| Lucy Bellardine Bataneant | Executive Officer | Halifax, A5 |
| Aravind Arepally | Executive Officer | Halifax, A5 |
| David Dobrowsky | Executive Officer | Halifax, A5 |
| Joseph Bellardine Siletto | Director | Halifax, A5 |
| James Bellardine McLaren | Director | Halifax, A5 |
| Marc Gregoire | Executive Officer | Halifax, A5 |
| Aaron Berez | Director | Halifax, A5 |
| Keten Patel | Director | Halifax, A5 |
| Anthony Headley | Executive Officer | Halifax, A5 |
| Carissa Bellardine Black | Director | Halifax, A5 |
| Mike Tyson | Executive Officer | Halifax, A5 |
| James Bellardine Eadie | Director | Halifax, A5 |
| Gary Donofrio | Executive Officer | Halifax, A5 |
| Michael Mangano | Director | Halifax, A5 |
| Michael Mangano | Executive Officer | Halifax, A5 |
| James McLaren | Director | Halifax, A5 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-11-03 | D | $2.6M | $2.6M |
| 2025-05-13 | D | $26.1M | $26.1M |
| 2022-12-22 | D/A | $28.5M | $28.5M |
| 2022-09-23 | D | $18.1M | $18.1M |